"Solemn Biotech began in 2006 with just 24 products to treat Psychiatry ailments. We have most successfully introduced our total range in DELHI, JAMMU & KASHMIR, BIHAR, UTTAR PRADESH, RAJSTHAN, GUJRAT, MAHARASTRA, MADHYA PRADESH,CHHATTISGARH, ANDHRA PRADESH, ASSAM, MEGHALAYA, WEST BENGAL, ORISSA, TRIPURA, KARNATAKA, HARIYANA, JHARKHAND etc.
Sales were rolled out nationally in 2006.
Realizing the fact that research is a critical growth driver, created a base of strong product and process development skills. Stake in Solemn Biotech. We used this money to build a Greenfield site for API manufacture, as well as for acquisitions. For the acquisitions, typically companies or assets that could be turned around and brought on track were identified.
We make specialty pharmaceuticals and active pharmaceutical ingredients. Our brands are prescribed in chronic therapy areas like, psychiatry, neurology, gastroenterology, and respiratory and dermatology.
We have the same drive for growth that marked our early days. Solemn Biotech came into existence as a startup with just 24 products in 2006. In the time since, We have reached leadership in each of the therapy areas that we operate in, and are rated among the leading companies by key customers. Strengthening market share and keeping this customer focus remains a high priority area for the company.
We have used a combination of internal growth and acquisitions to drive growth; Under a recent corporate development.
"Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment."
"We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases.
We shall provide…